FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly gastroenterology, and may be applied in treating lactase deficiency in adults. To do this, against the background of diet therapy, rifaximin is administered at a dose of 400–500 per day divided into 2 doses for 10–14 days, followed by the introduction of a combined probiotic linex forte for 1–3 capsules 2 times a day for 30–45 days.
EFFECT: method enables higher clinical effectiveness in lactase deficiency in adults.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSING THE SEVERITY OF IRRITABLE BOWEL SYNDROME | 2017 |
|
RU2668496C2 |
METHOD FOR ASSESSING CLINICAL EFFECTIVENESS IN IRRITABLE BOWEL SYNDROME ACCOMPANIED BY DIARRHOEA | 2014 |
|
RU2570767C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATIC STEATOSIS AND STEATOHEPATITIS | 2013 |
|
RU2545990C2 |
DIAGNOSTIC TECHNIQUE FOR ASYMPTOMATIC CELIAC DISEASE IN ADULTS | 2020 |
|
RU2747523C1 |
METHOD FOR ASSESSING EFFICACY OF NUTRITIONAL SUPPORT ACCOMPANYING ULCERATIVE COLITIS | 2013 |
|
RU2552319C1 |
DIAGNOSTIC METHOD OF DISACCHARIDASE DEFICIENCY IN ADULT PATIENTS | 2017 |
|
RU2655205C1 |
METHOD OF TREATING SECONDARY LACTASE DEFICIENCY | 2011 |
|
RU2477633C2 |
METHOD OF TREATING CHRONIC CONSTIPATION AND FUNCTIONAL ANOREXIA | 2013 |
|
RU2545988C1 |
METHOD FOR PREVENTING TUBERCULOSIS IN INFLAMMATORY INTESTINAL DISEASES | 2018 |
|
RU2712943C1 |
METHOD FOR DETERMINING RISK OF ISCHEMIC HEART DISEASE | 2013 |
|
RU2532361C1 |
Authors
Dates
2019-04-04—Published
2017-03-16—Filed